We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Prenatal Viral Exposure May Cause Type 1 Diabetes

By LabMedica International staff writers
Posted on 22 Oct 2014
Women who contract a viral infection during pregnancy transmit viruses to their genetically susceptible fetuses, sparking the development of type 1 diabetes. More...


The incidence of type 1childhood diabetes has been increasing rapidly worldwide and if blood sugar levels are not well-controlled, juvenile diabetes can affect nearly every organ of a child's body with long-term complications of the disease developing gradually that may become disabling and even life-threatening.

Scientists at the Tel Aviv University Sackler Faculty of Medicine (Tel Aviv, Israel) and their colleagues conducted blood tests of 107 healthy pregnant women, testing for islet cell autoantibodies which are evidence of diabetes that appears years before the initial symptoms. Maternal and cord blood sera from the pregnant women were tested for islet cell autoantibodies using radioligand binding assays and for anti-Rotavirus and anti-Coxsackievirus B3 (CoxB3) antibody using an enzyme-linked immunosorbent assay during different seasons.

The scientists found a striking difference between women tested in different seasons, suggesting a link to winter epidemics. The concurrent presence of glutamic acid decarboxylase (GAD65) antibodies in cord blood and their mothers indicated autoimmune damage to islet cells during gestation, possibly caused by cross-placental transmission of viral infections and/or antivirus antibodies. In other words, during viral epidemics of winter months, 10% of the healthy pregnant women who had no family background of autoimmune diseases tested positive for damaging antibodies.

For 5, 22 and 17 pregnancies, antibodies to GAD65, Rotavirus and CoxB3, respectively, were detected in cord blood only and not in the corresponding maternal serum. In 10 pregnancies, Rotavirus antibody titers in the cord blood exceeded those in the corresponding maternal serum by 2.5 to 5-fold. Increased antibody titers after the 20th week of gestation suggested CoxB3 infection in one of the 20 pregnancies and Rotavirus in another.

Zvi Laron, MD, professor emeritus of pediatric endocrinology and senior author of the study said, “If our hypothesis can be verified, then preventive vaccine before conception would be useful in stopping the increasing incidence of type 1 diabetes and other autoimmune diseases. There is no cure for this diabetes, so true intervention would be important not only medically but also psychologically and financially, as the costs of the lifelong treatment of this chronic disease and other autoimmune diseases are great.” The study was published in the June 2014 issue of the journal Diabetic Medicine.

Related Links:

Sackler Faculty of Medicine 



Gold Member
Veterinary Hematology Analyzer
Exigo H400
Serological Pipet Controller
PIPETBOY GENIUS
New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Chlamydia Trachomatis Test
Aptima Chlamydia Trachomatis Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.